Icure Pharmaceutical

CompanySouth Korea

Icure Pharmaceutical develops one asset, approved (donepezil in dementia). Mostly small molecule acting on ACHE; based in South Korea.

1
Asset
Furthest: Approved; 3
Trials: 0
Signals

Pipeline

1

donepezil
Reversible acetylcholinesterase inhibitor that elevates synaptic acetylcholine levels.
Approved, Small molecule, ACHE, dementia, Alzheimer's disease (Phase 3)

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms2
Trials3
Similar companies6

Updated 7 Oct 2026 · 36 sources